<DOC>
	<DOCNO>NCT02776878</DOCNO>
	<brief_summary>The purpose study determine whether dasatinib effective safe treatment refractory metastatic gastrointestinal stromal tumor</brief_summary>
	<brief_title>A Clinical Trial Evaluating Efficacy Safety Dasatinib Refractory Metastatic GIST</brief_title>
	<detailed_description />
	<mesh_term>Gastrointestinal Stromal Tumors</mesh_term>
	<mesh_term>Dasatinib</mesh_term>
	<criteria>Histologically confirm recurrent/metastatic gastrointestinal stromal tumor ( GIST ) . Immunohistochemically , detection KIT and/or DOG1 are/is positive Patients must measurable disease meeting requirement RECIST 1.1 Received gene mutation detection c kit/PDGFRA Subjects mutation exon 11 , exon 9 wild type ckit/PDGFRA fail imatinib sunitinib Subjects primary mutation exon 17 18 fail imatinib Subjects primary mutation exon 11 secondary mutation exon 17 18 fail imatinib Subjects mutation exon 18 PDGFRA , receive TKI Eastern Cooperative Oncology Group ( ECOG ) performance status = 02 Expected OS ≥3 month Ability understand willingness sign write informed consent document Subject comply study procedure therapy Local metastatic GIST resectable Unable receive gene mutation detection ckit ( ckitprotooncogeneprotein ) /PDGFRA AST and/or ALT &gt; 2.5 time ULN , Bilirubin &gt; 1.5 time upper limit normal ( ULN ) Neutrophil count &lt; 1.5 x 10^9/L , Platelet count &lt; 75 x 10^9/L , Hemoglobin &lt; 90g/L Cr &gt; 1.5×ULN Other malignancy within past 5 year except adequately treat carcinoma situ cervix cutaneous basal cell carcinoma Known brain metastasis , spinal cord compression , carcinomatous meningitis , cerebral soft meningeal disease CT MRI screen stage Within past 5 year , subject one follow disease : myocardial infarction , serious/instable angina pectoris , symptomatic congestive heart failure cerebrovascular accident coronary/peripheral artery bypass graft Known human immunodeficiency virus positivity Joining trail Women pregnant lactating ; No contraception subject childbearing period Subject serious acute chronic physical mental problem , laboratory abnormality , increase risk associated trail drug . It also interference judgment result . In judgment investigator , subject inadequate participant study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>